BIK and asthma: Increased transgenic expression of Bik in the airways also caused significant increases in TUNEL positivity compared to controls (Fig. 5g), suggesting that targeted expression of Bik is sufficient to reduce allergen-or CS-induced mucous cells in models of asthma and chronic bronchitis by inducing cell death of hyperplastic cells.